Please use this identifier to cite or link to this item: https://open.uns.ac.rs/handle/123456789/14194
DC FieldValueLanguage
dc.contributor.authorMarija Vukojaen_US
dc.contributor.authorIvan Kopitovićen_US
dc.contributor.authorZorica Lazićen_US
dc.contributor.authorBranislava Milenkovićen_US
dc.contributor.authorIvana Stankovićen_US
dc.contributor.authorBiljana Zvezdinen_US
dc.contributor.authorAleksandra Dudvarski Ilićen_US
dc.contributor.authorIvana Čekerevacen_US
dc.contributor.authorMiodrag Vukčevićen_US
dc.contributor.authorVladimir Žugićen_US
dc.contributor.authorSanja Hromišen_US
dc.date.accessioned2020-03-03T14:55:19Z-
dc.date.available2020-03-03T14:55:19Z-
dc.date.issued2019-01-01-
dc.identifier.issn11769106en_US
dc.identifier.urihttps://open.uns.ac.rs/handle/123456789/14194-
dc.description.abstract© 2019 Vukoja et al. In recent years, several national chronic obstructive pulmonary disease (COPD) guidelines have been issued. In Serbia, the burden of COPD is high and most of the patients are diagnosed at late stages. Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy is poorly implemented in real-life practice, as many patients are still prescribed inhaled corticosteroids (ICS)-containing regimens and slow-release theophylline. In this document, we propose an algorithm for treating COPD patients in Serbia based on national experts’ opinion, taking into account global recommendations and recent findings from clinical trials that are tailored according to local needs. We identified four major components of COPD treatment based on country specifics: Active case finding and early diagnosis in high-risk population, therapeutic algorithm for initiation and escalation of therapy that is simple and easy to use in real-life practice, de-escalation of ICS in low-risk non-exacerbators, and individual choice of inhaler device based on patients' ability and preferences. With this approach we aim to facilitate implementation of the recommendation, initiate the treatment in early stages, improve cost-effectiveness, reduce possible side effects, and ensure efficient treatment.en_US
dc.language.isoenen_US
dc.relation.ispartofInternational Journal of COPDen_US
dc.subjectCOPDen_US
dc.subjecttreatmenten_US
dc.subjectguidelinesen_US
dc.titleDiagnosis and management of chronic obstructive pulmonary disease in Serbia: An expert group position statementen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.doi10.2147/COPD.S214690-
dc.identifier.pmid14-
dc.identifier.scopus2-s2.0-85072746075-
dc.identifier.urlhttps://api.elsevier.com/content/abstract/scopus_id/85072746075-
dc.description.versionPublisheden_US
dc.relation.lastpage2002en_US
dc.relation.firstpage1993en_US
dc.relation.volume14en_US
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptMedicinski fakultet, Katedra za internu medicinu-
crisitem.author.deptMedicinski fakultet, Katedra za internu medicinu-
crisitem.author.deptMedicinski fakultet, Katedra za internu medicinu-
crisitem.author.deptMedicinski fakultet, Katedra za zdravstvenu negu-
crisitem.author.parentorgMedicinski fakultet-
crisitem.author.parentorgMedicinski fakultet-
crisitem.author.parentorgMedicinski fakultet-
crisitem.author.parentorgMedicinski fakultet-
Appears in Collections:MDF Publikacije/Publications
Show simple item record

SCOPUSTM   
Citations

12
checked on May 10, 2024

Page view(s)

40
Last Week
10
Last month
4
checked on May 10, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.